Introduction: Exit-site infection (ESi) prevention is a key factor in lowering the risk of peritonitis. This study aimed to evaluate the associations between exit-site (ES) care protocols and the annual incidence rates of ESi and peritonitis in Portugal. Methods: We performed a national survey using two questionnaires: one about the incidence of catheter-related infections and the other characterizing patients’ education and ES care protocols. Results: In 2017 and 2018, 14 Portuguese units followed 764 and 689 patients. ESi incidence rate was 0.41 episodes/year, and the peritonitis incidence rate was 0.37. All units monitor catheter-related infections on a yearly basis, use antibiotic prophylaxis at the time of catheter placement, and treat nasal carriage of S. aureus, although with different approaches. Screening for nasal carriage of S. aureus is performed by 12 units, and daily topical antibiotic cream is recommended by 6 out of 14 of the units. We did not find statistical differences in ESi/peritonitis, comparing these practices. The rate of ESis was lower with nonocclusive dressing immediately after catheter insertion, bathing without ES dressing, with the use of colostomy bags in beach baths and was higher with the use of bath sponge. The peritonitis rate was lower with bathing without ES dressing and if shaving of the external cuff was performed in the presence of chronic ESi. Conclusions: We found potential proceedings associated with ESi and peritonitis. A regular national audit of peritoneal dialysis units is an important tool for clarifying the best procedures for reduction of catheter-related infections.

1.
Kramer A, Boenink R, Stel VS, Santiuste de Pablos C, Tomović F, Golan E, et al. The ERA-EDTA registry annual report 2018: a summary. Clin Kidney J. 2021;14(1):107–23.
2.
Galvão AFR, Carvalho MJ, Leal R, Lopes JA, Amoedo M, Silva G. Portuguese registry of dialysis and transplantation 2020 Sociedade Portuguesa de Nefrologia; 2020. www.spnefro.pt.
3.
Teitelbaum I. Peritoneal dialysis. N Engl J Med. 2021;385(19):1786–95.
4.
Szeto CC, Li PK, Johnson DW, Bernardini J, Dong J, Figueiredo AE, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141–54.
5.
Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int. 2006;70(103):S55–62.
6.
van Diepen ATN, Tomlinson GA, Jassal SV. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients. Clin J Am Soc Nephrol. 2012;7(8):1266–71.
7.
van Esch S, Struijk DG, Krediet RT. The natural time course of membrane alterations during peritoneal dialysis is partly altered by peritonitis. Perit Dial Int. 2016;36(4):448–56.
8.
Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int. 2011;31(6):651–62.
9.
Fontán MP, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005;25(3):274–84.
10.
Cho Y, Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis. 2014;64(2):278–89.
11.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
12.
Ambruso SL, Teitelbaum I. Prevention of peritoneal dialysis drop-out. Adv Perit Dial. 2018;34:19–23.
13.
Nataatmadja M, Cho Y, Johnson DW. Continuous quality improvement initiatives to sustainably reduce peritoneal dialysis-related infections in Australia and New Zealand. Perit Dial Int. 2016;36(5):472–7.
14.
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, et al. Ispd peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
15.
Ferreira ACSJ, Amoedo M, Oliveira A, Silva R, Malho-Guedes A. On behalf of the peritoneal dialysis’ study group of the Portuguese society of nephrology. Current guidelines in peritoneal dialysis: part I. Port J Nephrol Hypert. 2019;33(1):28–35.
16.
Perl J, Fuller DS, Bieber BA, Boudville N, Kanjanabuch T, Ito Y, et al. Peritoneal dialysis-related infection rates and outcomes: results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53.
17.
Vernier I, Fabre E, Dratwa M, Verger C. Peritoneal catheter infections: data from the French language peritoneal dialysis registry (RDPLF), risk factors. Bull Dial Domic. 2019;2(3):135–41.
18.
Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EMC. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37(12):1629–38.
You do not currently have access to this content.